VLX Ventures
The AI engine Fit Assessment
BetaVLX Ventures focuses on pharma tech through its early-stage biotech and digital pharma investments, including drug development and computational biology, with seed investments and follow-ons, plus mentoring and networking support for portfolio companies such as Everly Bio, Point6 Bio, Protica Bio, and others.
Blurb
HQ Location
Founded
Employees
Total funding raised
Funding Status
We invest in early-stage startups led by exceptional entrepreneurs. Our sweet spots are computational biology and drug development and delivery.
Our seed investments are around $1m, and we do follow-on investments.
Our highly versatile and experienced team provides entrepreneurs with extensive mentoring and networking support. Our experience and know-how, combined with our financial backing and administrative assistance, give early-stage startups all the tools they need to grow and thrive.